Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors
Authors:
- 18 March 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 160 (4) , 835-843
Abstract
Background Digital ulcers (DU) are a major complication in the course of systemic sclerosis (SSc). In recent years, efficacious, but expensive therapies (e.g. iloprost, sildenafil, bosentan) have been shown to improve healing or to reduce the recurrence of DU. For optimal management it would be useful to identify the risk factors for DU. Such statistical analyses have been rare because they require a high number of patients. Objectives To identify potential risk factors for DU in patients with SSc. Methods We used the registry of the German Network for Systemic Scleroderma and evaluated the data of 1881 patients included by August 2007. We assessed potential risk factors for DU by comparing patients with (24.1%) and without active DU at time of entry (75.9%). Results Multivariate analysis revealed that male sex, presence of pulmonary arterial hypertension (PAH), involvement of the oesophagus, diffuse skin sclerosis (only when PAH was present), anti‐Scl70 antibodies, young age at onset of Raynaud’s phenomenon (RP), and elevated erythrocyte sedimentation rate (ESR) significantly impacted on the appearance of DU. Certain combinations increased the patients’ probability of presenting with DU, with the highest probability (88%) for male patients with early onset of RP, ESR > 30 mm h−1, anti‐Scl70 antibodies and PAH. Patients with DU developed RP, skin sclerosis and organ involvement approximately 2–3 years earlier than patients without DU. Conclusions The results reveal possible risk factors for the occurrence of DU in SSc. As DU are prone to local complications, prophylactic vasoactive treatment for patients presenting with these factors may be justified.Keywords
This publication has 17 references indexed in Scilit:
- The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvementRheumatology, 2008
- Management of cutaneous vascular complications in systemic scleroderma: experience from the German networkRheumatology International, 2008
- Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature ReviewSeminars in Arthritis and Rheumatism, 2008
- Raynaud-Phänomen in der DermatologieDie Dermatologie, 2006
- Vasoactive therapies in systemic sclerosisRheumatology, 2006
- Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonistArthritis & Rheumatism, 2004
- Systemic SclerosisMedicine, 2002
- European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centresAnnals of the Rheumatic Diseases, 2001
- Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind studyArthritis & Rheumatism, 1998
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988